Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-04-05 @ 4:35 AM
Study NCT ID:
NCT07443202
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2026-03-02
First Post:
2026-02-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Sponsor:
Tarsus Pharmaceuticals, Inc.
Organization:
Study Overview
Official Title:
A Randomized, Vehicle-Controlled, Multicenter, Double-Masked, Parallel, Phase 2 Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of Lotilaner Ophthalmic Gel in Participants With Ocular Rosacea (KORE)
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate lotilaner treatment in patients with ocular rosacea.
Detailed Description:
To evaluate safety of lotilaner compared to vehicle control in the treatment of ocular rosacea.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: